[
  {
    "ts": null,
    "headline": "Top Stock Reports for UnitedHealth, Costco & IBM",
    "summary": "Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Costco Wholesale Corporation (COST) and International Business Machines Corporation (IBM), as well as a micro-cap stock Smith-Midland Corporation (SMID).",
    "url": "https://finnhub.io/api/news?id=e0005970289a921b1ad035973a686ea822f109ad4f38bc74cb8847b7c17144c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735936260,
      "headline": "Top Stock Reports for UnitedHealth, Costco & IBM",
      "id": 132259785,
      "image": "https://media.zenfs.com/en/zacks.com/58724708490e67ef1bafc8867f3885b5",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Costco Wholesale Corporation (COST) and International Business Machines Corporation (IBM), as well as a micro-cap stock Smith-Midland Corporation (SMID).",
      "url": "https://finnhub.io/api/news?id=e0005970289a921b1ad035973a686ea822f109ad4f38bc74cb8847b7c17144c8"
    }
  },
  {
    "ts": null,
    "headline": "BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business",
    "summary": "Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.",
    "url": "https://finnhub.io/api/news?id=8b3464b7f2d259216dcda2c08b44b2e1b1068f164e3d9df2c16bd102873eee86",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735919580,
      "headline": "BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business",
      "id": 132255244,
      "image": "https://media.zenfs.com/en/zacks.com/b35c1538fbd501bfb8e20b349661fde7",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Bioventus aims to improve its focus and execution within its core businesses and enhance liquidity following the divestiture.",
      "url": "https://finnhub.io/api/news?id=8b3464b7f2d259216dcda2c08b44b2e1b1068f164e3d9df2c16bd102873eee86"
    }
  },
  {
    "ts": null,
    "headline": "3 GARP Stocks That Investors Can Scoop Up for Maximum Returns",
    "summary": "Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, RJF and KBR are some stocks that hold promise.",
    "url": "https://finnhub.io/api/news?id=064a9f2b93b2258b371285ed9f63a1a79110aa805f577543391ef8b06950d87e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735910940,
      "headline": "3 GARP Stocks That Investors Can Scoop Up for Maximum Returns",
      "id": 132257607,
      "image": "https://media.zenfs.com/en/zacks.com/3485a80ca9f149b05be325eb24f7ab6b",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RMD, RJF and KBR are some stocks that hold promise.",
      "url": "https://finnhub.io/api/news?id=064a9f2b93b2258b371285ed9f63a1a79110aa805f577543391ef8b06950d87e"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain Inari Medical Stock in Your Portfolio for Now",
    "summary": "NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.",
    "url": "https://finnhub.io/api/news?id=ac0e1afb6fcc8bae5400e22dd8fbd98de23c5a166702ee2d2dd1530a92d0b600",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735910880,
      "headline": "Reasons to Retain Inari Medical Stock in Your Portfolio for Now",
      "id": 132253903,
      "image": "https://media.zenfs.com/en/zacks.com/b66321e586fa6fdc44309f696ff0a17a",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "NARI continues to gain from its expanded product portfolio. The company's expansion in China and Japan bodes well.",
      "url": "https://finnhub.io/api/news?id=ac0e1afb6fcc8bae5400e22dd8fbd98de23c5a166702ee2d2dd1530a92d0b600"
    }
  },
  {
    "ts": null,
    "headline": "ResMed Gains 37.8% in a Year: What's Driving the Stock?",
    "summary": "RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is concerning.",
    "url": "https://finnhub.io/api/news?id=55d44c92daef63bba0e478e223e7f78993a0b573546802a25b64fe4258211fa2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735910460,
      "headline": "ResMed Gains 37.8% in a Year: What's Driving the Stock?",
      "id": 132257610,
      "image": "https://media.zenfs.com/en/zacks.com/4658663242c3a61dee3fef55a1bf4887",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "RMD's shares gain on the back of robust mask and device sales growth. However, the unfavorable macroeconomic scenario is concerning.",
      "url": "https://finnhub.io/api/news?id=55d44c92daef63bba0e478e223e7f78993a0b573546802a25b64fe4258211fa2"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain Phibro Stock in Your Portfolio Now",
    "summary": "PAHC's prospering Vaccine business sparks optimism for future growth. However, headwinds such as unfavorable foreign exchange might hamper the company's operations.",
    "url": "https://finnhub.io/api/news?id=70462669092b7c841f357bfa6a014e1aca09e3f8a9b2bca3e64bb81e3d3269f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735907640,
      "headline": "Reasons to Retain Phibro Stock in Your Portfolio Now",
      "id": 132253484,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "PAHC's prospering Vaccine business sparks optimism for future growth. However, headwinds such as unfavorable foreign exchange might hamper the company's operations.",
      "url": "https://finnhub.io/api/news?id=70462669092b7c841f357bfa6a014e1aca09e3f8a9b2bca3e64bb81e3d3269f1"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain Medtronic Stock in Your Portfolio Now",
    "summary": "Investors continue to be optimistic about MDT due to its impressive Neuroscience portfolio. Yet, the dull macroeconomic scenario poses a concern to the company's margins.",
    "url": "https://finnhub.io/api/news?id=c85834a831279126fe4521dc56145c0cd1ebecdc1cdcbb0708c87d585493ca0e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735907100,
      "headline": "Reasons to Retain Medtronic Stock in Your Portfolio Now",
      "id": 132253485,
      "image": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Investors continue to be optimistic about MDT due to its impressive Neuroscience portfolio. Yet, the dull macroeconomic scenario poses a concern to the company's margins.",
      "url": "https://finnhub.io/api/news?id=c85834a831279126fe4521dc56145c0cd1ebecdc1cdcbb0708c87d585493ca0e"
    }
  }
]